Advertisement

Related Videos

Amit Sanyal, MD: A Clinician’s Perspective

Welcome and Introduction to Vi3C

Varsha Gandhi, PhD, on Ibrutinib

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Opening Session Panel Discussion

Advertisement

Advertisement




Dec
17
Today In Oncology
Flipped Nivolumab/Ipilimumab Dosing Improves Outcomes in Advanced Melanoma
Tanning Bed Exposure and Melanoma Risks
FLIPI24: New Prognostic Model for Newly Diagnosed Follicular Lymphoma
HER2-Positive Breast Cancer FDA Approves T-DXd Plus Pertuzumab
Phase III Trial Shows No Oncologic Benefit From Routine Preoperative MRI for Some Early Breast Cancers
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo